Congenital heart disease in India: a status report

Anita Saxena1

  • 1Department of Cardiology, Cardiothoracic Centre, All India Institute of Medical, Sciences, New Delhi-110 029, India. anitasaxena@hotmail.com

Insights

Pediatric cardiac care in India faces significant challenges, including a lack of data and inadequate resources for congenital heart disease (CHD). Establishing specialized training and a national policy is crucial for improving pediatric heart health.

Area of Science:

  • Cardiology
  • Pediatrics
  • Public Health

Background:

  • Pediatric cardiac care in India is underdeveloped, lacking essential data on congenital heart disease (CHD) prevalence and mortality.
  • Limited and improperly utilized resources, coupled with a scarcity of specialized training programs, hinder effective pediatric cardiac care.
  • The absence of a national policy for pediatric heart care exacerbates existing challenges.

Purpose of the Study:

  • To highlight the critical deficiencies in India's pediatric cardiac care infrastructure.
  • To emphasize the need for improved data collection, resource allocation, and specialized training programs.
  • To advocate for the development of a national policy to address congenital heart disease in children.

Main Methods:

  • This study is a review and analysis of the current state of pediatric cardiac care in India.
  • It identifies gaps in prevalence data, resource availability, and specialized training programs.
  • The analysis also considers the impact of limited national policy and awareness.

Main Results:

  • There is a significant lack of data on congenital heart disease (CHD) prevalence and mortality in India.
  • Resources for pediatric cardiology and cardiac surgery are scarce and often inefficiently used.
  • Specialized training programs are few, regionally concentrated, and often integrated with adult programs, leading to an inadequate number of trained professionals.

Conclusions:

  • Urgent need to establish dedicated pediatric cardiology and cardiac surgery training programs in high-standard centers.
  • Increasing awareness among pediatricians through continuous medical education is vital for early diagnosis and referral.
  • Development and implementation of a national policy for pediatric heart care are essential to address the current shortcomings.

Related Concept Videos

Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Development of the Heart01:27

Development of the Heart

The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart tube by...
Mitral Stenosis I: Introduction01:22

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...